Infinity to Present At Rodman & Renshaw Annual Global Investment Conference


CAMBRIDGE, Mass., Nov. 5, 2008 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Steven H. Holtzman, chair and chief executive officer, will be presenting a company overview at the Rodman & Renshaw Annual Global Investment Conference in New York. Infinity's presentation will take place on November 12, 2008 at 11:10 a.m. EST.

A live webcast of Infinity's presentation will be accessible on the company's website at http://www.infi.com and will be archived on the website for 30 days.

About Infinity Pharmaceuticals, Inc.

Infinity is an innovative cancer drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging cancer pathways. Infinity's two most advanced programs in Hsp90 inhibition and Hedgehog signaling pathway inhibition are evidence of its innovative approach to oncology drug discovery and development. For more information on Infinity, please refer to the company's website at http://www.infi.com.



            

Contact Data